ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

New Subcontracts Planned In Bioassay Program Run by Traco-JITCO

May 23, 1975

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Sen. Grassley Presses Amgen on “Bundling.”

April 11, 2008

Research Integrity: Collins’ Student Falsified Data, ORI Finds

August 22, 1997

Health Groups Urge FDA To Regulate Tobacco Products, Including E-Cigarettes

September 5, 2014

DC Board Okay One Recompetition, Disapproves Two

November 12, 1982